Phase 2b TARGET Trial Results Show Improved Survival in Adenocarcinoma ...
The data show that patients in the predefined adenocarcinoma subgroup treated with the vintafolide plus docetaxel combination had a 27 percent reduction in risk of the disease worsening or death (HR=0.73, p=0.0899, one-sided test), and a 30 percent ...
MarketWatch - Sat, 27 Sep 2014 07:16

Endocytes TARGET Interim Data Positive for Lung Cancer
Zacks.com - Mon, 29 Sep 2014 13:31

Why Endocyte, Inc. Stock Briefly Spiked Higher
Motley Fool - Mon, 29 Sep 2014 10:26

Metastatic NSCLC: New Findings, New Avenues to Explore
HealthCanal.com - Sun, 28 Sep 2014 14:45

Surveillance of Barrett's Esophagus and Mortality From Esophageal ...
Objectives: Barrett's esophagus (BE) is associated with an increased risk of developing esophageal adenocarcinoma (EAC). Patients with a known diagnosis of BE are usually advised to participate in an endoscopic surveillance program, but its clinical ...
Medscape - Mon, 01 Sep 2014 21:07

PET Screening for Metastatic Colorectal Adenocarcinoma—Reply
In Reply Drs Wong and Jolepalem and Dr Hofman and colleagues question the value of PET after preoperative chemotherapy. In our trial, a baseline CT was used to decide if the patient was a candidate for hepatic surgery. Most patients (70%) had received ...
JAMA: The Journal of the American Medical Association - Tue, 23 Sep 2014 13:03

Nintedanib* receives positive CHMP opinion for second-line treatment of ...
Adenocarcinoma is the most common type of lung cancer and accounts for nearly half of all NSCLC cases. The majority of patients with advanced adenocarcinoma will experience disease progression after first-line chemotherapy and there is still a ...
Business Wire (press release) - Fri, 26 Sep 2014 04:26

XAGE1 antibody confers survival benefits to lung adenocarcinoma patients
Patients with advanced lung adenocarcinoma who produce the XAGE1 (GAGED2a) antibody appear to survive twice as long as those who do not produce it, Japanese study data show. Eiichi Nakayama (Kawasaki University of Medical Welfare, Okayama) ...
News-Medical.net - Wed, 24 Sep 2014 14:11

Lung Adenocarcinoma-Pipeline Insights, 2014
A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Lung Adenocarcinoma. This report provides information on the therapeutic development based on the Lung Adenocarcinoma dealing with all the ...
MarketWatch - Wed, 03 Sep 2014 12:17



Understanding Bladder Cancer -Adenocarcinoma
Adenocarcinoma, this is a cancer that begins in glandular (secretory) cells that may form in the bladder after long-term irritation and inflammation. This type of bladder cancer is rare in the United States. There are other types of bladder cancer ...
Cancer - Sun, 14 Sep 2014 22:03

New oesophageal adenocarcinoma guidelines
Cancer Council Australia has published new clinical guidelines aimed at providing consistency in the management of Barrett's oesophagus and oesophageal adenocarcinoma (OAC). The guidelines, which the council says are the first of their kind in ...
Gastroenterology Update - Mon, 15 Sep 2014 18:36


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014